Facebook



Twitter

Insights

Browse Through Our Interesting Case Studies And Know How We Excel At Precise Diagnosis Of Different Types Of Cancer

1. EGFR Mutation in Non-Small Cell Lung Cancer by Liquid Biopsy When Solid Not Feasible
The editorial and review of the literature on liquid biopsy ctDNA EGFR mutation not only highlights its concordance with tissue EGFR mutation but also emphasizes its importance in the early detection of resistant mutation in patients receiving tyrosine kinase inhibitor (TKI) therapy.

2. Spectrum of Germline BRCA Mutations in Hereditary Breast and Ovarian Cancer Syndrome in Indian Population: A Central Reference Laboratory Experience
There is a growing need for BRCA1/BRCA2 mutation frequencies among hereditary breast and ovarian carcinoma (HBOC) cases, specifically determined on the grounds of personal and family history profiles in the Indian population. The current study was intended to identify BRCA1/2 mutation frequency and spectrum in Indian women fulfilling the National Comprehensive Cancer Network criteria.

3. Multidisciplinary Tumour Board has another Member – Molecular
There is a growing need for BRCA1/BRCA2 mutation frequencies among hereditary breast and ovarian carcinoma (HBOC) cases, specifically determined on the grounds of personal and family history profiles in the Indian population. The current study was intended to identify BRCA1/2 mutation frequency and spectrum in Indian women fulfilling the National Comprehensive Cancer Network criteria.

In our years of experience, we have come across many interesting cases! Each one of it has provided for rich learning and a humbling one at that. Please take a look at our case gallery and tell us what you think. Drop a mail at oncomet@metropolisindia.com


TESTS PROCESSED AT

Global Refernce Laboratory Metropolis Healthcare Limited
4th Floor, Commercial Building -1A, Kohinoor City Mall,Off LBS Marg, Vidyavihar (West), Mumbai – 400070. Tel : 022-50560787
For more details write to us at oncomet@metropolisindia.com